The proposal would cut funds to the Centers for Disease Control and Prevention and the National Institutes of Health. However, no reduction was suggested for the Food and Drug Administration. 

Currently in development, the “Generation Gold Standard” platform utilizes inert whole viruses to combat more strains of common illnesses, such as COVID and the flu. It’s on track for FDA approval in 2029.

The vendor's latest earnings report outlines a nearly $35 million decline in mammography sales and projected ramifications from new tariffs. 

Nabil Dib, MD, founder of the International Society for Cardiovascular Translational Research, details resources to help doctors and startups navigate the shift from conducting research to commercializing new products and applications.

ACR’s request comes amid ongoing trade wars and new tariffs placed on imaging products. 

The declaration comes with the North Billerica, Massachusetts-based drugmaker announcing positive results from two “pivotal” studies of MK-6240. 

Overpromising AI capabilities to hospital stakeholders—now there’s a mistake healthcare AI enthusiasts have been known to make.

The newly approved device can be worn for up to a week at a time, with no daily maintenance required, and includes advanced AI algorithms that minimize the risk of false alarms or inappropriate shocks.